With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced it has received FDA 510 (k) clearance for its next-generation vMap ® technology. The clearance ...